Answers are grounded in this paper and cite their sources.
Phenotypic screening is a powerful strategy for identifying bioactive compounds in physiologically relevant systems. Here, we present a protocol for evaluating tumor necrosis factor (TNF)-induced changes in intracellular ATP as a viability readout. We describe steps for organoid expansion in type I collagen gel, recovery of organoids, dissociation into a homogeneous single-cell/small-cluster suspension, TNF stimulation and compound treatment, and measurement of intracellular ATP levels. This protocol addresses variability arising from the three-dimensional nature of organoids and introduces strategies to minimize such variability. For complete details on the use and execution of this protocol, please refer to Takahashi et al. 1 1. Takahashi, Y. ∙ Zhang, Z. ∙ Tanaka, I. ... Organoid phenotypic screening identified glycyrrhizin that confers protection against tumor necrosis factor-induced cell death Stem Cell Rep. 2026; 21 , 102891 Full Text Full Text (PDF)
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: